Asia Business News | Saturday, July 05, 2008
RSS 2.0  
The development of novel antisense pharmaceuticals for commercially important human conditions.
Company Fax (03) 9827 1166 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 2001/12/20 
Company Homepage www.antisense.com.au/
 
Stock Exchange Stock Code
  ASX:ANPANP
ADR QUOTEATHJY
 PINK:ATHJYATHJY
News Reader RSS   ANTISENSE THERAPEUTICS LIMITED
Drag Podcast Icon To iTunes - Podcast Download for ANTISENSE THERAPEUTICS LIMITED
 ANTISENSE THERAPEUTICS LIMITED ASX: ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO (JUNE 29, 2006)